Toll Free: 1-888-928-9744
Published: Feb, 2016 | Pages:
38 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Sirnaomics, Inc. - Product Pipeline Review - 2016 Summary Global Markets Direct's, 'Sirnaomics, Inc. - Product Pipeline Review - 2016', provides an overview of the Sirnaomics, Inc.'s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by Sirnaomics, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data. Scope - The report provides a snapshot of the pipeline therapeutic landscape of Sirnaomics, Inc. - The report provides overview of Sirnaomics, Inc. including its business description, key facts, and locations and subsidiaries - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report assesses Sirnaomics, Inc.'s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type - The report features Sirnaomics, Inc.'s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects Reasons to Buy - Evaluate Sirnaomics, Inc.'s strategic position with total access to detailed information on its product pipeline - Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for Sirnaomics, Inc. - Identify potential new clients or partners in the target demographic - Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding Sirnaomics, Inc.'s pipeline depth and focus of pipeline therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
Table of Contents Table of Contents 2 List of Tables 5 List of Figures 5 Sirnaomics, Inc. Snapshot 6 Sirnaomics, Inc. Overview 6 Key Information 6 Key Facts 6 Sirnaomics, Inc. - Research and Development Overview 7 Key Therapeutic Areas 7 Sirnaomics, Inc. - Pipeline Review 10 Pipeline Products by Stage of Development 10 Pipeline Products - Monotherapy 11 Sirnaomics, Inc. - Pipeline Products Glance 12 Sirnaomics, Inc. - Early Stage Pipeline Products 12 IND/CTA Filed Products/Combination Treatment Modalities 12 Preclinical Products/Combination Treatment Modalities 13 Discovery Products/Combination Treatment Modalities 14 Sirnaomics, Inc. - Drug Profiles 15 STP-705 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 STP-302 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 STP-503 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 STP-523 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 STP-601 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 STP-702 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 STP-801 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 STP-900 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 STP-902 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 STP-909 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 STP-703 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 STP-805 27 Product Description 27 Mechanism of Action 27 R&D Progress 27 STP-911 28 Product Description 28 Mechanism of Action 28 R&D Progress 28 STP-916 29 Product Description 29 Mechanism of Action 29 R&D Progress 29 Sirnaomics, Inc. - Pipeline Analysis 30 Sirnaomics, Inc. - Pipeline Products by Target 30 Sirnaomics, Inc. - Pipeline Products by Route of Administration 31 Sirnaomics, Inc. - Pipeline Products by Molecule Type 32 Sirnaomics, Inc. - Pipeline Products by Mechanism of Action 33 Sirnaomics, Inc. - Recent Pipeline Updates 34 Sirnaomics, Inc. - Dormant Projects 35 Sirnaomics, Inc. - Locations And Subsidiaries 36 Head Office 36 Other Locations & Subsidiaries 36 Appendix 37 Methodology 37 Coverage 37 Secondary Research 37 Primary Research 37 Expert Panel Validation 37 Contact Us 37 Disclaimer 38
List of Tables Sirnaomics, Inc., Key Information 6 Sirnaomics, Inc., Key Facts 6 Sirnaomics, Inc. - Pipeline by Indication, 2016 8 Sirnaomics, Inc. - Pipeline by Stage of Development, 2016 10 Sirnaomics, Inc. - Monotherapy Products in Pipeline, 2016 11 Sirnaomics, Inc. - IND/CTA Filed, 2016 12 Sirnaomics, Inc. - Preclinical, 2016 13 Sirnaomics, Inc. - Discovery, 2016 14 Sirnaomics, Inc. - Pipeline by Target, 2016 30 Sirnaomics, Inc. - Pipeline by Route of Administration, 2016 31 Sirnaomics, Inc. - Pipeline by Molecule Type, 2016 32 Sirnaomics, Inc. - Pipeline Products by Mechanism of Action, 2016 33 Sirnaomics, Inc. - Recent Pipeline Updates, 2016 34 Sirnaomics, Inc. - Dormant Developmental Projects,2016 35 Sirnaomics, Inc., Subsidiaries 36
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.